Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models
From MaRDI portal
Recommendations
- A PDE model for imatinib-treated chronic myelogenous leukemia
- An ``age-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia
- Long-term treatment effects in chronic myeloid leukemia
- New Computational Tools for Modeling Chronic Myelogenous Leukemia
- HYBRID SIMULATION ALGORITHMS FOR AN AGENT-BASED MODEL OF THE IMMUNE RESPONSE
Cited in
(9)- An ``age-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia
- Controlled stochastic partial differential equations for rabbits on a grassland
- Optimal harvesting for a predator-prey agent-based model using difference equations
- Long-term treatment effects in chronic myeloid leukemia
- Solutions of differential-difference equations arising from mathematical models of granulocytopoiesis
- Data and implication based comparison of two chronic myeloid leukemia models
- Control of a consumer‐resource agent‐based model using partial differential equation approximation
- Stability analysis of a simplified yet complete model for chronic myelogenous leukemia
- A PDE model for imatinib-treated chronic myelogenous leukemia
This page was built for publication: Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q941121)
